(0.13%) 5 314.98 points
(0.16%) 39 871 points
(0.03%) 16 800 points
(-0.58%) $79.34
(-0.80%) $2.73
(-0.20%) $2 433.60
(0.07%) $32.45
(0.48%) $1 068.80
(0.07%) $0.921
(-0.26%) $10.67
(-0.08%) $0.786
(-0.51%) $90.22
4.38% $ 1.670
Live Chart Being Loaded With Signals
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases...
Stats | |
---|---|
Volumen de hoy | 531 056 |
Volumen promedio | 1.94M |
Capitalización de mercado | 210.01M |
EPS | $0 ( 2024-05-20 ) |
Próxima fecha de ganancias | ( $-0.0500 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.96 |
ATR14 | $0.00400 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Finn Jonathan | Buy | 25 000 | Common Stock |
2024-03-09 | Cigler Tessa | Buy | 20 834 | Stock Option (right to buy) |
2024-03-09 | Cigler Tessa | Buy | 0 | |
2023-11-15 | Weaver Gregory L | Sell | 50 000 | Common Stock |
2023-11-15 | Finn Jonathan | Buy | 62 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
70.91 |
Last 98 transactions |
Buy: 26 594 652 | Sell: 4 017 362 |
Atossa Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
GIFI | 0.952 |
LFMDP | 0.948 |
SG | 0.946 |
RPAY | 0.937 |
RGLS | 0.929 |
SWBI | 0.929 |
CPRT | 0.926 |
PUBM | 0.926 |
MNMD | 0.925 |
DXPE | 0.924 |
10 Correlaciones Más Negativas | |
---|---|
RETO | -0.916 |
RGF | -0.911 |
UONEK | -0.909 |
EEIQ | -0.909 |
HRZN | -0.909 |
TCPC | -0.905 |
CLEU | -0.901 |
TTEC | -0.898 |
QNRX | -0.897 |
GAN | -0.897 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Atossa Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-23 000.00 (0.00 %) |
EPS: | $-0.240 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-23 000.00 (0.00 %) |
EPS: | $-0.240 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-8 000.00 (0.00 %) |
EPS: | $-0.210 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.180 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Atossa Therapeutics Inc
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico